| Literature DB >> 29558419 |
Caitlin R Woolcott1,2, Stephanie Torrey3,4, Patricia V Turner5,6, Lilia Serpa7,8, Karen Schwean-Lardner9, Tina M Widowski10,11.
Abstract
On-farm euthanasia is a critical welfare issue in the poultry industry and can be particularly difficult to perform on mature turkeys due to their size. We evaluated the efficacy of two commercially available non-penetrating captive bolt devices, the Zephyr-EXL and the Turkey Euthanasia Device (TED), on 253 turkeys at three stages of production: 4-5, 10, and 15-20 weeks of age. Effectiveness of each device was measured using both ante- and post-mortem measures. Application of the Zephyr-EXL resulted in a greater success rate (immediate abolishment of brainstem reflexes) compared to the TED (97.6% vs. 89.3%, p = 0.0145). Times to last movement (p = 0.102) and cardiac arrest (p = 0.164) did not differ between devices. Ante- and post-mortem measures of trauma and hemorrhage were highly correlated. Skull fractures and gross subdural hemorrhage (SDH) were present in 100% of birds euthanized with both the Zephyr-EXL and TED devices. Gross SDH scores were greater in birds killed with the Zephyr-EXL than the TED (p < 0.001). Microscopic SDH scores indicated moderate to severe hemorrhage in 92% of turkeys for the Zephyr-EXL and 96% of turkeys for the TED, with no difference between devices (p = 0.844). Overall, both devices were highly effective inducing immediate insensibility through traumatic brain injury and are reliable, single-step methods for on-farm euthanasia of turkeys.Entities:
Keywords: animal welfare; brain death; euthanasia; insensibility; turkey
Year: 2018 PMID: 29558419 PMCID: PMC5867530 DOI: 10.3390/ani8030042
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Figure 1The non-penetrating captive bolt device (Zephyr-EXL) with safety pin inserted (a) and with subject adapter removed and bolt head exposed (b) [36].
Figure 2The non-penetrating captive bolt device (Turkey Euthanasia Device). (a) Device with adapter 1; (b) Device with adapter removed and bolt head exposed; (c) Subject adapters [36].
Description of sample sizes and device distribution across age, sex, farm, and operator.
| Age (Weeks) | Average Weight (kg) | Sex | Number of Farms | Number of Operators | Device | Sample Size |
|---|---|---|---|---|---|---|
| 4–5 | 1.3 | Female | 2 | 1 | TED | 22 |
| Zephyr-EXL | 21 | |||||
| 2.0 | Male | 1 | 3 | TED | 29 | |
| Zephyr-EXL | 20 | |||||
| 10 | 4.0 | Female | 1 | 1 | TED | 19 |
| Zephyr-EXL | 19 | |||||
| 8.0 | Male | 1 | 3 | TED | 21 | |
| Zephyr-EXL | 20 | |||||
| 15–20 | 10.0 | Female | 1 | 1 | TED | 20 |
| Zephyr-EXL | 20 | |||||
| 14.9 | Male | 3 | 5 | TED | 20 | |
| Zephyr-EXL | 22 |
Figure 3An example of the restraint method (a) and correct placement of the device (b) during the euthanasia trial.
List of reflexes, description, and procedure use, recorded in order of observation after application of each killing method.
| Measure | Description | Procedure |
|---|---|---|
| Pupillary | Constriction of the pupil in response to light | Light from a medical penlight was directed into the eye |
| Nictitating | Transient closure of the nictitating membrane in response to mechanical stimulation | The medial canthus of the eye was lightly touched with a fingertip |
| Gasping | Deep breathing with the mouth open wide | Visual observation for an open beak with irregular deep breaths |
| Jaw Tone | Resistance due to downward pressure applied to the jaw | Gentle pressure was applied to the lower jaw with a finger |
| Tonic | Muscle rigidity with final paddling motions with the legs and wings stretched | The time of cessation of all movement was recorded. Convulsions ceased when the limbs were relaxed |
| Clonic | Episodes of wing-flapping | See Tonic. |
| Cardiac Arrest | Cessation of heart beat | Palpation of brachial and femoral arteries, and indirect auscultation |
Macroscopic scoring criteria for trauma, fracture and hemorrhage, modified from [19,22].
| Score | Skull Fracture | External Hemorrhage and Skin Laceration | Subdural Hemorrhage |
|---|---|---|---|
| 0 | No fracture, intact skull | No laceration the skin | No hemorrhage |
| 1 | Depression fracture * | Laceration of the skin with no external hemorrhage | <25% of surface area covered |
| 2 | Penetrating fracture/no imbedded fragments | Laceration of the skin with external hemorrhage | 26–50% of surface area covered |
| 3 | Penetrating fracture/with imbedded fragments | N/A | 51–75% of surface area covered |
| 4 | N/A | N/A | 75–100% of surface area covered |
* Depression fractures are incomplete fractures and penetrating fractures are complete fractures.
Number of failures by device type, bird age, sex, and adapter selection.
| Age (Weeks) | Device | Sex | Number of Failures | Adapter | |
|---|---|---|---|---|---|
| 4–5 | TED | Female | 22 | 2 | 3 |
| Male | 29 | 7 | 2,3 | ||
| Zephyr-EXL | Female | 21 | 0 | N/A | |
| Male | 20 | 1 | N/A | ||
| 10 | TED | Female | 19 | 1 | 2, 3 |
| Male | 21 | 1 | 2 | ||
| Zephyr-EXL | Female | 19 | 0 | N/A | |
| Male | 20 | 0 | N/A | ||
| 15–20 | TED | Female | 20 | 1 | 2 |
| Male | 20 | 2 | 1 | ||
| Zephyr-EXL | Female | 20 | 0 | N/A | |
| Male | 22 | 2 | N/A |
Number of birds presenting with reflexes and involuntary behaviours following application of the Turkey Euthanasia Device (TED) and Zephyr-EXL.
| Reflex | Device | Age (Weeks) | Total | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 4–5 | 10 | 15–20 | Device | Age | Device × Age | ||||
| Pupillary * | TED | 131 | 9 | 2 | 3 | 14 c | 0.139 | 0.206 | |
| Zephyr-EXL | 122 | 1 | 0 | 2 | 3 d | ||||
| Nictitating * | TED | 131 | 9 | 2 | 3 | 14 c | 0.139 | 0.206 | |
| Zephyr-EXL | 122 | 1 | 0 | 2 | 3 d | ||||
| Gasping | TED | 117 | 2 a | 0 a | 6 c,b | 8 c | |||
| Zephyr-EXL | 119 | 0 | 0 | 0 d | 0 d | ||||
| Jaw Tone | TED | 117 | 0 a | 0 a | 5 b | 5 | 0.902 | 0.6300 | |
| Zephyr-EXL | 119 | 0 | 1 | 4 | 5 | ||||
* Scores includes turkeys that were deemed failures. a,b Indicates differences observed within age by device. c,d Indicates differences observed within age. Bold is used to indicate significance.
Average end time of last movement and cardiac arrest for turkeys killed using either device (TED and Zephyr-EXL) across three age groups (4–5 weeks, 10 weeks, and 15–20 weeks), in addition to the mean value of the device by age interaction.
| Device | ||||||
|---|---|---|---|---|---|---|
| Age (Weeks) | TED | Zephyr-EXL | Mean for Age | Device | Age | Device × Age |
| 4–5 | 186 ± 11.9 | 139 ± 13.3 | 163 ± 9.2 c | 0.102 | ||
| 10 | 200 ± 9.6 a | 170 ± 6.6 b | 185 ± 6.04 d | |||
| 15–20 | 178 ± 11.7 | 209 ± 10.1 | 194 ± 7.9 d | |||
| Overall | 188 ± 6.5 | 173 ± 6.5 | ||||
| 4–5 | 209 ± 11.3 c | 185 ± 12.1 c | 197 ± 8.3 c | 0.164 | ||
| 10 | 246 ± 10.0 a,d | 198 ± 5.9 b,c | 222 ± 6.4 d | |||
| 15–20 | 228 ± 10.9 | 260 ± 8.4 d | 244 ± 7.0 d | |||
| Overall | 227 ± 6.3 | 214 ± 6.1 | ||||
a,b Indicates differences observed within age. c,d Indicates differences observed within age difference by device. Bold is used to indicate significance.
Figure 4Cumulative frequency distribution for (a) time to last movement (s) and (b) time of apparent cardiac arrest (s) for turkeys killed with Zephyr-EXL or TED. Time point 0 indicates the time of application of the device.
Distribution of macroscopic hemorrhage scores following application of the Turkey Euthanasia Device (TED) and Zephyr-EXL.
| Variable * | Device | Age | Score | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 4 | Device | Age | Device × Age | ||||
| EHSL | TED | 4–5 | 42 | 3 | 1 | 38 | N/A | N/A | 0.930 | 0.455 | |
| 10 | 38 | 5 | 4 | 29 | |||||||
| 15–20 | 37 | 3 | 9 | 25 | |||||||
| Total | 117 | 11 | 14 | 92 | |||||||
| Zephyr-EXL | 4–5 | 40 | 11 | 3 | 26 | ||||||
| 10 | 39 | 7 | 2 | 30 | |||||||
| 15–20 | 40 | 1 | 2 | 37 | |||||||
| Total | 119 | 19 | 7 | 93 | |||||||
| Skull Fx | TED | 4–5 | 42 | 0 | 0 | 0 | 42 | N/A | 1.000 | 1.00 | 1.000 |
| 10 | 38 | 0 | 0 | 1 | 37 | ||||||
| 15–20 | 37 | 0 | 0 | 4 | 33 | ||||||
| Total | 117 | 0 | 0 | 5 | 112 | ||||||
| Zephyr-EXL | 4–5 | 40 | 0 | 0 | 0 | 40 | |||||
| 10 | 39 | 0 | 0 | 2 | 37 | ||||||
| 15–20 | 40 | 0 | 0 | 0 | 40 | ||||||
| Total | 119 | 0 | 0 | 2 | 117 | ||||||
| SC | TED | 4–5 | 42 | 0 | 0 | 0 | 3 | 39 | 0.143 | 0.851 | |
| 10 | 38 | 0 | 1 | 1 | 2 | 34 | |||||
| 15–20 | 37 | 1 | 10 | 5 | 7 | 14 | |||||
| Total | 117 | 1 | 11 | 6 | 12 | 87 | |||||
| Zephyr-EXL | 4–5 | 40 | 0 | 0 | 2 | 0 | 38 | ||||
| 10 | 39 | 0 | 1 | 0 | 1 | 37 | |||||
| 15–20 | 40 | 0 | 4 | 6 | 7 | 23 | |||||
| Total | 119 | 0 | 5 | 8 | 8 | 98 | |||||
| SDH | TED | 4–5 | 42 | 0 | 3 | 8 | 17 | 14 | |||
| 10 | 38 | 0 | 2 | 9 | 17 | 10 | |||||
| 15–20 | 37 | 0 | 1 | 6 | 20 | 10 | |||||
| Total | 117 | 0 | 6 | 23 | 54 | 34 | |||||
| Zephyr-EXL | 4–5 | 40 | 0 | 0 | 1 | 5 | 34 | ||||
| 10 | 39 | 0 | 1 | 2 | 3 | 33 | |||||
| 15–20 | 39 | 0 | 2 | 10 | 7 | 20 | |||||
| Total | 118 | 0 | 3 | 13 | 15 | 87 | |||||
* External hemorrhage and skin laceration (EHSL), skull fracture (Skull Fx), subcutaneous hemorrhage (SC), and subdural hemorrhage (SDH). Bold is used to indicate significance.
Distribution of microscopic hemorrhage scores following application of the Turkey Euthanasia Device (TED) and Zephyr-EXL.
| Variable | Device | Score | ||||||
|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 4 | Device | |||
| SDH | 24 | TED | 0 | 1 | 7 | 16 | 0 | 0.844 |
| 12 | Zephyr-EXL | 0 | 1 | 2 | 9 | 0 | ||
| PH | 24 | TED | 0 | 4 | 7 | 13 | 0 | 0.301 |
| 12 | Zephyr-EXL | 1 | 1 | 4 | 6 | 0 | ||
* p-values indicates the probability of hemorrhage score variation as a result of device differences for subdural (SDH) and parenchymal (PH) hemorrhage.
Distribution of microscopic hemorrhage scores by age.
| Variable | Age (Weeks) | Score | ||||||
|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 4 | Age | |||
| SDH | 4–5 | 5 | 0 | 0 | 0 | 0 | 5 | 0.787 |
| 10 | 12 | 0 | 0 | 1 | 3 | 8 | ||
| 15–20 | 19 | 0 | 0 | 1 | 6 | 12 | ||
| PH | 4–5 | 5 | 0 | 0 | 1 | 2 | 2 | 0.253 |
| 10 | 12 | 1 | 0 | 3 | 3 | 5 | ||
| 15–20 | 19 | 0 | 0 | 1 | 6 | 12 | ||
* p-values indicates the probability of hemorrhage score variation as a result of age differences for subdural (SDH) and parenchymal (PH) hemorrhage.